Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-01-10 @ 3:03 PM
Study NCT ID:
NCT03822351
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2018-12-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-18
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-10
First Submit QC Date:
None
Study First Post Date:
2019-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-01
Results First Submit QC Date:
None
Results First Post Date:
2024-10-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-04
Last Update Post Date:
2024-10-08
Last Update Post Date Type:
ACTUAL